3,655 results on '"Rappuoli, Rino"'
Search Results
2. Next generation of “magic bullets”, solutions from the microbial pangenome
3. The evolving landscape of live attenuated COVID-19 vaccines
4. Deep-learning image analysis for high-throughput screening of opsono-phagocytosis-promoting monoclonal antibodies against Neisseria gonorrhoeae
5. Antonello Covacci (1957–2023), a visionary and beautiful mind
6. Discovery and characterization of a pan-betacoronavirus S2-binding antibody
7. Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses
8. Scientists’ call to action: Microbes, planetary health, and the Sustainable Development Goals
9. Transforming vaccinology
10. A next-generation GMMA-based vaccine candidate to fight shigellosis
11. Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children
12. B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response
13. Save the microbes to save the planet. A call to action of the International Union of the Microbiological Societies (IUMS)
14. mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5
15. Functional diversification of innate and inflammatory immune responses mediated by antibody fragment crystallizable activities against SARS-CoV-2
16. Primary cancer prevention for cancers with no known infectious etiology: Time for a new paradigm
17. SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
18. Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action
19. Challenges in synthesis of real-world vaccine effects on meningococcal serogroup B disease for 4CMenB vaccine post-licensure effectiveness studies: A systematic review
20. Historical Advances in Structural and Molecular Biology and How They Impacted Vaccine Development
21. Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis
22. Technologies for Making New Vaccines
23. Contributors
24. A Lean Reverse Vaccinology Pipeline with Publicly Available Bioinformatic Tools
25. Immune response in COVID-19: what is next?
26. Vaccine Discovery and Translation of New Vaccine Technology
27. Classical- and bioconjugate vaccines: comparison of the structural properties and immunological response
28. Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations
29. Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
30. Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens
31. Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injection
32. Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 Study.
33. ANTICORPI E VACCINI: DUE FACCE DELLA STESSA MEDAGLIA.
34. Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19
35. Vaccinology in the post−COVID-19 era
36. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules
37. Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants
38. Standing the test of COVID-19: charting the new frontiers of medicine
39. Functional diversification of innate and inflammatory immune responses mediated by antibody Fc activities against SARS-CoV-2
40. Development of a visual Adhesion/Invasion Inhibition Assay to assess the functionality of Shigella-specific antibodies
41. B cell maturation restored ancestral germlines to control Omicron BA.2.86
42. The Pangenome: A Data-Driven Discovery in Biology
43. Structure of a protective epitope reveals the importance of acetylation of Neisseria meningitidis serogroup A capsular polysaccharide
44. Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM 197 conjugate vaccine
45. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
46. Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults
47. Challenges for Vaccinologists in the First Half of the Twenty-First Century
48. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
49. The role of vaccines in combatting antimicrobial resistance
50. 4CMenB Immunization Induces Serum Bactericidal Antibodies Against Non-Serogroup B Meningococcal Strains in Adolescents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.